EORTC 1945 OligoRARE trial in oligometastatic rare cancers receives support by Anticancer Fund & Rising Tide
EORTC 1945 OligoRARE trial in oligometastatic rare cancers receives support by Anticancer Fund & Rising Tide February 2, 2021 Brussels – EORTC 1945 OligoRARE trial in stereotactic body radiotherapy in addition to standard of care treatment in patients with oligometastatic rare cancers, receives significant financial contribution by the Anticancer Fund and the Rising Tide Foundation …